What guidance did management provide for Q3 and FY2026 earnings, cash flow, and capital requirements?
Guidance Summary (as disclosed by management in the release)
- Q3 2025 – Management said the company expects to post a contribution profit roughly in line with the Q2 result, i.e., around the $1 million‑$1.2 million mark, with the EBITDA loss narrowing another ≈ 45 %‑50 % versus the same quarter a year ago.
- FY 2026 – The team reaffirmed its FY‑2026 outlook that the EBITDA margin will turn positive, targeting c. 5 %–7 % of revenue (roughly a $5 million‑$7 million EBITDA surplus) once repeat‑usage growth and cost‑efficiency initiatives fully materialise.
- Cash‑flow – Management highlighted that operating cash flow is expected to become positive in FY 2026, driven by higher contribution profit and tighter working‑capital management (lower vehicle‑turn‑over costs and reduced marketing spend).
- Capital Requirements – The firm said it will continue to fund growth primarily from internal cash generation, with only modest incremental capex of $10 million‑$12 million through FY 2026 for fleet expansion, technology upgrades and market‑entry initiatives. No major external financing is anticipated.
Trading Implications
The guidance points to a clear path toward profitability and positive cash flow, which should reduce the discount to earnings that the market currently applies to ZCAR. If the company can hit the FY‑2026 EBITDA target, the stock could see a 15 %‑20 % upside from current levels, especially as the share price has already priced in a steep Q2 loss reduction. From a technical standpoint, ZCAR is trading near the 200‑day moving average and has formed a bullish flag on the daily chart; a break above the recent high (~$4.85) with volume would be a catalyst to capture the upside. Conversely, any miss on the Q3 contribution‑profit number or a signal of higher‑than‑expected capex could trigger a short‑term pull‑back, so keep a stop‑loss just below the $4.30 support zone. Overall, the guidance supports a long‑biased stance with a target price of $5.50–$6.00, assuming the company stays on its cost‑efficiency trajectory.